What is it about?
Whole landscape of personalized cancer treatment is introduced. It includes drug sensitivity testing, biomarkers, pharmacogenomics, cost-effective and others. New experimental details and variations between different approaches are outlined and discussed.
Featured Image
Photo by Long (lTiga) Nguyen on Unsplash
Why is it important?
Major architectures of PM and clinical potentiality
Perspectives
It is medical article that contain overall information of most disciplines
Professor Da Yong Lu
Shanghai University
Read the Original
This page is a summary of: Personalized Cancer Therapy: A Perspective, Clinical and Experimental Pharmacology, January 2014, OMICS Publishing Group,
DOI: 10.4172/2161-1459.1000153.
You can read the full text:
Contributors
The following have contributed to this page
